Endpoint definition
↥| Name | OTHER_DRUGADVERS_SECONDA_PARKINSONI |
|---|---|
| Long name | Other drug-induced secondary parkinsonism |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Name | OTHER_DRUGADVERS_SECONDA_PARKINSONI |
|---|---|
| Long name | Other drug-induced secondary parkinsonism |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 148 | 73 | 75 |
| Unadjusted prevalence (%) | 0.07 | 0.06 | 0.08 |
| Mean age at first event (years) | 58.15 | 59.56 | 56.79 |
| Case fatality at 5-years (%) | 5.41 | 4.11 | 6.67 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 22.97 | 19.18 | 26.67 |
before Other drug-induced secondary parkinsonism
after Other drug-induced secondary parkinsonism
Loading survival analyses plot…
Loading survival analyses table…